Axa’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,200
Closed -$1.2M 1246
2020
Q4
$1.2M Hold
13,200
﹤0.01% 941
2020
Q3
$528K Hold
13,200
﹤0.01% 1031
2020
Q2
$453K Sell
13,200
-12,700
-49% -$436K ﹤0.01% 1080
2020
Q1
$575K Buy
+25,900
New +$575K ﹤0.01% 947